BioPharmaTrend
News
All Topics
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
  • Interviews
  • Business Intelligence
  • Case Studies
Intelligence
  • Business Intelligence
  • Case Studies
  • Lab
  • Membership
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
  • Write for Us
Newsletter
Login/Join
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Biotech Ventures
  • Industry Movers
  • NeuroTech
This company is included in Intelligence Lab

Cloud Pharmaceuticals

Cloud Pharmaceuticals logo

Website
http://www.cloudpharmaceuticals.com/
Founded
2009

Technologies

AI Companies (Drug Discovery) Pharmaceutical and Drug Discovery

Cloud Pharmaceuticals delivers novel molecular designs of ligands to your druggable targets using our Quantum Molecular Design process deployed on cloud-based high performance computing platforms. The process is run by Cloud Pharmaceuticals' experts in a high-throughput production environment and has three components:

- An artificial Intelligence search of virtual chemical space
- Highly accurate binding affinity prediction
- Chemical property filters for drug-like properties, safety, and synthesizability

Drug Discovery Partnerships


Articles Mentioning This Company

[Interview] Adoption Of AI Technologies By The Life Sciences Professionals: What Is Coming In 2018?

[Interview] Adoption of AI-driven Tools By The Life Sciences Professionals: What Is Coming In 2018?

Jan. 18, 2018     Interviews
The previous year was rich in discussions and events one way or another related to potential applications of artificial intelligence (AI) advances for the benefit of drug discovery and development. (Note: For the sake of simplicity, the term “AI” will be applied herein interchangeably with terms like “machine learning” (ML), …

R&D Platform

Cloud Pharmaceuticals designs new drugs and drug candidates and accelerates the development process by implementing new, innovative cloud computing technology in place of traditional methods. We manage development of multiple assets through an extensive network of partners. This reduces cost, decreases development time, and creates novel molecules with therapeutic value.

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Citations and Press Coverage
  • Terms of Use
  • Privacy Policy
  • Disclaimer

We Offer


  • Newsletter
  • Business Intelligence
  • Interviews
  • Partner Events
  • Case Studies

Opportunities


  • Advertise
  • Lab Access
  • Lab Membership
  • Write for Us
  • Contact Us

© BPT Analytics LTD 2025
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.